These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34065899)

  • 1. Long-Term Anti-Bacterial Immunity against Systemic Infection by
    Fiorino F; Pettini E; Koeberling O; Ciabattini A; Pozzi G; Martin LB; Medaglini D
    Vaccines (Basel); 2021 May; 9(5):. PubMed ID: 34065899
    [No Abstract]   [Full Text] [Related]  

  • 2. IgG Responses to Porins and Lipopolysaccharide within an Outer Membrane-Based Vaccine against Nontyphoidal
    Schager AE; Dominguez-Medina CC; Necchi F; Micoli F; Goh YS; Goodall M; Flores-Langarica A; Bobat S; Cook CNL; Arcuri M; Marini A; King LDW; Morris FC; Anderson G; Toellner KM; Henderson IR; López-Macías C; MacLennan CA; Cunningham AF
    mBio; 2018 Mar; 9(2):. PubMed ID: 29511082
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Hanumunthadu B; Kanji N; Owino N; Ferreira Da Silva C; Robinson H; White R; Ferruzzi P; Nakakana U; Canals R; Pollard AJ; Ramasamy M;
    BMJ Open; 2023 Nov; 13(11):e072938. PubMed ID: 37963701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of O-antigen delivered by Generalized Modules for Membrane Antigens (GMMA) vaccine candidates against nontyphoidal Salmonella.
    De Benedetto G; Alfini R; Cescutti P; Caboni M; Lanzilao L; Necchi F; Saul A; MacLennan CA; Rondini S; Micoli F
    Vaccine; 2017 Jan; 35(3):419-426. PubMed ID: 27998639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative immunogenicity and efficacy of equivalent outer membrane vesicle and glycoconjugate vaccines against nontyphoidal
    Micoli F; Rondini S; Alfini R; Lanzilao L; Necchi F; Negrea A; Rossi O; Brandt C; Clare S; Mastroeni P; Rappuoli R; Saul A; MacLennan CA
    Proc Natl Acad Sci U S A; 2018 Oct; 115(41):10428-10433. PubMed ID: 30262653
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Gasperini G; Massai L; De Simone D; Raso MM; Palmieri E; Alfini R; Rossi O; Ravenscroft N; Kuttel MM; Micoli F
    Front Cell Infect Microbiol; 2024; 14():1347813. PubMed ID: 38487353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of a Bivalent Adjuvanted Glycoconjugate Vaccine against
    Fiorino F; Rondini S; Micoli F; Lanzilao L; Alfini R; Mancini F; MacLennan CA; Medaglini D
    Front Immunol; 2017; 8():168. PubMed ID: 28289411
    [No Abstract]   [Full Text] [Related]  

  • 8. Generalized Modules for Membrane Antigens (GMMA), an outer membrane vesicle-based vaccine platform, for efficient viral antigen delivery.
    Hu K; Palmieri E; Samnuan K; Ricchetti B; Oldrini D; McKay PF; Wu G; Thorne L; Fooks AR; McElhinney LM; Goharriz H; Golding M; Shattock RJ; Micoli F
    J Extracell Vesicles; 2022 Nov; 11(11):e12247. PubMed ID: 36377074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-Like Receptor Activation by Generalized Modules for Membrane Antigens from Lipid A Mutants of Salmonella enterica Serovars Typhimurium and Enteritidis.
    Rossi O; Caboni M; Negrea A; Necchi F; Alfini R; Micoli F; Saul A; MacLennan CA; Rondini S; Gerke C
    Clin Vaccine Immunol; 2016 Apr; 23(4):304-14. PubMed ID: 26865597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GMMA and Glycoconjugate Approaches Compared in Mice for the Development of a Vaccine against
    Raso MM; Gasperini G; Alfini R; Schiavo F; Aruta MG; Carducci M; Forgione MC; Martini S; Cescutti P; Necchi F; Micoli F
    Vaccines (Basel); 2020 Apr; 8(2):. PubMed ID: 32260067
    [No Abstract]   [Full Text] [Related]  

  • 11. Nontyphoidal salmonella disease: Current status of vaccine research and development.
    Tennant SM; MacLennan CA; Simon R; Martin LB; Khan MI
    Vaccine; 2016 Jun; 34(26):2907-2910. PubMed ID: 27032517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a glycoconjugate vaccine to prevent invasive Salmonella Typhimurium infections in sub-Saharan Africa.
    Baliban SM; Yang M; Ramachandran G; Curtis B; Shridhar S; Laufer RS; Wang JY; Van Druff J; Higginson EE; Hegerle N; Varney KM; Galen JE; Tennant SM; Lees A; MacKerell AD; Levine MM; Simon R
    PLoS Negl Trop Dis; 2017 Apr; 11(4):e0005493. PubMed ID: 28388624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of O-Antigen Chain Length Regulation on the Immunogenicity of
    Gasperini G; Raso MM; Arato V; Aruta MG; Cescutti P; Necchi F; Micoli F
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Highly Effective Component Vaccine against Nontyphoidal Salmonella enterica Infections.
    Ferreira RB; Valdez Y; Coombes BK; Sad S; Gouw JW; Brown EM; Li Y; Grassl GA; Antunes LC; Gill N; Truong M; Scholz R; Reynolds LA; Krishnan L; Zafer AA; Sal-Man N; Lowden MJ; Auweter SD; Foster LJ; Finlay BB
    mBio; 2015 Sep; 6(5):e01421-15. PubMed ID: 26396246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal and systemic immune responses to chimeric fimbriae expressed by Salmonella enterica serovar typhimurium vaccine strains.
    Chen H; Schifferli DM
    Infect Immun; 2000 Jun; 68(6):3129-39. PubMed ID: 10816454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a novel trivalent invasive non-typhoidal Salmonella outer membrane vesicles based vaccine against salmonellosis and fowl typhoid in chickens.
    Maiti S; Halder P; Banerjee S; Dutta M; Kumar Mukhopadhyay A; Dutta S; Koley H
    Immunobiology; 2022 Mar; 227(2):152183. PubMed ID: 35121180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of protective immunity against Streptococcus mutans colonization after mucosal immunization with attenuated Salmonella enterica serovar typhimurium expressing an S. mutans adhesin under the control of in vivo-inducible nirB promoter.
    Huang Y; Hajishengallis G; Michalek SM
    Infect Immun; 2001 Apr; 69(4):2154-61. PubMed ID: 11254570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal Antibodies Elicited by Immunization With an O- Polysaccharide Glycoconjugate Vaccine Protect Infant Mice Against Lethal
    Baliban SM; Curtis B; Amin MN; Levine MM; Pasetti MF; Simon R
    Front Immunol; 2019; 10():2124. PubMed ID: 31555302
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Necchi F; Stefanetti G; Alfini R; Palmieri E; Carducci M; Di Benedetto R; Schiavo F; Aruta MG; Giusti F; Ferlenghi I; Goh YS; Rondini S; Micoli F
    Pathogens; 2021 Jun; 10(6):. PubMed ID: 34207575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulated Delayed
    Su H; Liu Q; Wang S; Curtiss R; Kong Q
    Theranostics; 2019; 9(12):3565-3579. PubMed ID: 31281498
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.